机译:人类乳腺癌基因组中体细胞重排的复杂情况
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Lancer Research, 237 Fulham Road, London SW3 6JB, UK;
Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA,Rotterdam, ThQ Netherlands;
Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA,Rotterdam, ThQ Netherlands;
Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA;
Department of Genetics, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway;
Department of Genetics, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway;
Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA,Rotterdam, ThQ Netherlands;
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Lancer Research, 237 Fulham Road, London SW3 6JB, UK;
The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The Netherlands;
Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA;
Department of Genetics, Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, 0310 Oslo, Norway;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK Institute of Cancer Research, 5utton, Surrey SM2 5NG, UK;
机译:通过使用全外显子组测序分析人类癌症中的体细胞基因组重排
机译:全基因组芯片对人的MCF7乳腺癌上皮细胞中TOP2B占有率的全基因组芯片全基因组分析全基因组芯片对人的MCF7乳腺癌上皮细胞中TOP2B占有率的全基因组ChIP-seq分析细胞
机译:全基因组芯片对人的MCF7乳腺癌上皮细胞中TOP2B占有率的全基因组芯片全基因组分析全基因组芯片对人的MCF7乳腺癌上皮细胞中TOP2B占有率的全基因组ChIP-seq分析细胞
机译:利用全基因组表达和体细胞突变分析相结合的精确乳腺癌生存预测
机译:癌症和人类基因组中的基因组重排。
机译:体细胞重排在乳腺癌癌症基因组复杂LaNDsCapEs
机译:人乳腺癌基因组中体细胞重排的复杂情况。